RUSSO, ELISA
 Distribuzione geografica
Continente #
EU - Europa 2.437
AS - Asia 36
SA - Sud America 14
NA - Nord America 2
Totale 2.489
Nazione #
IT - Italia 2.435
CN - Cina 20
BR - Brasile 10
VN - Vietnam 9
SG - Singapore 6
AR - Argentina 4
US - Stati Uniti d'America 2
ID - Indonesia 1
MT - Malta 1
NL - Olanda 1
Totale 2.489
Città #
Genoa 1.666
Vado Ligure 340
Genova 235
Rapallo 191
Beijing 12
Singapore 4
Ho Chi Minh City 3
Ashburn 2
Buenos Aires 2
Boca Toma 1
Bordighera 1
Brasília 1
Carangola 1
Dracena 1
Florianópolis 1
Haiphong 1
Hanoi 1
Hải Dương 1
Ibiraçu 1
Laferrere 1
Maceió 1
Matias Barbosa 1
Natal 1
Paracambi 1
Pindorama 1
Sliema 1
Thái Bình 1
Vĩnh Tường 1
Totale 2.474
Nome #
Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy 101
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma? 97
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 89
Effects of Different Dialysis Strategies on Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients with COVID-19: A Randomized Trial 87
How to Overcome Anabolic Resistance in Dialysis-Treated Patients? 86
Altered adiponectin regulation in skeletal muscle of patients with chronic kidney disease 83
Coexposure to microplastic and Bisphenol A exhacerbates damage to human kidney proximal tubular cells 81
Central line-associated bloodstream infections in hemodialysis patients in the COVID-19 era 77
Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review 76
Acute kidney injury in hematological patients treated with CAR-T cells: risk factors, clinical presentation and impact on outcomes 76
Hyperkalemia-induced acute flaccid paralysis: a case report 75
Fructose and uric acid: Major mediators of cardiovascular disease risk starting at pediatric age 74
Uric acid in CKD: has the jury come to the verdict? 71
Extracorporeal Carbon Dioxide Removal: From Pathophysiology to Clinical Applications; Focus on Combined Continuous Renal Replacement Therapy 67
Long-term blood pressure behavior and progression to end-stage renal disease in patients with immunoglobulin A nephropathy: a single-center observational study in Italy 67
Changes of Acute Kidney Injury Epidemiology during the COVID-19 Pandemic: A Retrospective Cohort Study 66
Adiponectin removal by the human kidney: A preliminary study 65
Long-term blood pressure variability, incidence of hypertension and changes in renal function in type 2 diabetes 62
Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis 61
Treating Hyperuricemia: The Last Word Hasn't Been Said Yet 61
Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs 57
Duration of antibiotic therapy in pyelonephritis: when shorter is better 56
Sglt2is and renal protection: From biological mechanisms to real-world clinical benefits 55
Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategies 50
SGLT2 inhibition to target kidney aging 49
null 49
The Evolving Scenario of COVID-19 in Hemodialysis Patients 48
Acute kidney injury in hospitalized patients with real-life analysis of incidence and clinical impact in Italian hospitals (the SIN-AKI study) 44
Risk factors for community-acquired acute kidney injury: Challenges and perspectives 43
Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes 41
Role of Renal Parenchyma Attenuation and Perirenal Fat Stranding in Chest CT of Hospitalized Patients with COVID-19 41
Pathophysiology of Physical Exercise in Kidney Patients: Unveiling New Players- The Role of Myokines 40
Asymptomatic Hyperuricemia and the Kidney: Lessons from the URRAH Study 37
The role of uric acid in renal damage: A history of inflammatory pathways and vascular remodeling 36
Relationship between uric acid and kidney function in adults at risk for tumor lysis syndrome 36
The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort 35
Serum Uric Acid, Hypertriglyceridemia, and Carotid Plaques: A Sub-Analysis of the URic Acid Right for Heart Health (URRAH) Study 34
Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components 32
Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project 32
Hypoglycemia in Patients With End-Stage Kidney Disease 30
The URRAH study 28
Serum uric acid and left ventricular mass index independently predict cardiovascular mortality: The uric acid right for heart health (URRAH) project 27
Risk of Cardiovascular Events in Metabolically Healthy Overweight or Obese Adults: Role of LDL-Cholesterol in the Stratification of Risk 27
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis 24
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (URRAH Project) 23
MEDICINA INTERNA: Metodologia, Semeiotica, Fisiopatologia, Clinica, Terapia Medica 23
Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study 22
The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation 22
Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional‐Based Italian Database 21
IGF-1 Signaling Modulates Oxidative Metabolism and Stress Resistance in ARPE-19 Cells Through PKM2 Function 20
Serum Uric Acid/Serum Creatinine Ratio and Cardiovascular Mortality in Diabetic Individuals—The Uric Acid Right for Heart Health (URRAH) Project 17
Hemoadsorption as a Supportive Strategy for Severe Toxicity Associated With Chimeric Antigen Receptor T-Cell Therapy: A Case Series 16
Impact of GFR on Mortality Risk After Biliopancreatic Diversion: Challenges and Pitfalls for the Clinician 4
Saltiness Perception and Sodium Intake in Patients With Chronic Kidney Disease 2
Totale 2.643
Categoria #
all - tutte 12.230
article - articoli 12.146
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 84
Totale 24.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202180 0 0 0 0 0 0 11 10 11 21 14 13
2021/2022128 5 3 5 0 8 15 2 36 6 23 6 19
2022/2023254 16 15 2 20 34 36 16 18 42 5 36 14
2023/2024229 8 27 7 33 18 49 7 12 8 3 16 41
2024/20251.047 32 41 47 62 120 98 100 178 43 84 109 133
2025/2026859 228 114 279 231 7 0 0 0 0 0 0 0
Totale 2.643